Skip to main content
Top
Published in: Supportive Care in Cancer 4/2017

01-04-2017 | Original Article

Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment

Authors: Seoyon Yang, Dae Hwan Park, Sei Hyun Ahn, Jisun Kim, Jong Won Lee, Jun Young Han, Dong Kyu Kim, Jae Yong Jeon, Kyoung Hyo Choi, Won Kim

Published in: Supportive Care in Cancer | Issue 4/2017

Login to get access

Abstract

Purpose

The present study investigated the prevalence and risk factors of adhesive capsulitis of the shoulder in breast cancer patients between 13 and 18 months after surgery.

Methods

This study included 271 women who underwent surgery for breast cancer with a postoperative period of 13–18 months. Current adhesive capsulitis was defined as restriction of external rotation and one or more additional directional restrictions with history of shoulder pain. Cumulative adhesive capsulitis was defined as current adhesive capsulitis or a previous history of adhesive capsulitis after breast cancer surgery. Multivariate logistic regression analysis was performed to examine associations between current or cumulative adhesive capsulitis and potential risk factors.

Results

Among the 271 study patients, 28 (10.3%) and 21 (7.7%) had cumulative or current adhesive capsulitis, respectively. The incidences of cumulative and current adhesive capsulitis were higher in those aged 50–59 years (odds ratio [OR], 9.912; 95% confidence interval [CI], 1.790–54.880; and OR, 12.395; 95% CI, 1.187–129.444, respectively) and those who underwent mastectomy (OR, 6.805; 95% CI, 1.800–25.733; and OR, 9.645; 95% CI, 2.075–44.829, respectively) or mastectomy with reconstruction (OR, 13.122; 95% CI, 2.488–69.218; and OR, 20.075; 95% CI, 2.873–140.261, respectively).

Conclusions

Adhesive capsulitis of the shoulder is a common problem after breast cancer treatment. An age of 50–59 years and mastectomy are major risk factors for adhesive capsulitis, and breast reconstruction additionally increases the risk. Patients with these risk factors require greater attention for early diagnosis and proper treatment.
Literature
6.
go back to reference Neviaser AS, Neviaser RJ (2011) Adhesive capsulitis of the shoulder. J Am Acad Orthop Surg 19:536–542CrossRef Neviaser AS, Neviaser RJ (2011) Adhesive capsulitis of the shoulder. J Am Acad Orthop Surg 19:536–542CrossRef
9.
go back to reference Ranalletta M, Rossi LA, Bongiovanni SL, Tanoira I, Elizondo CM, Maignon GD (2016) Corticosteroid injections accelerate pain relief and recovery of function compared with oral NSAIDs in patients with adhesive capsulitis: a randomized controlled trial. Am J Sports Med 44:474–481. doi:10.1177/0363546515616238 CrossRefPubMed Ranalletta M, Rossi LA, Bongiovanni SL, Tanoira I, Elizondo CM, Maignon GD (2016) Corticosteroid injections accelerate pain relief and recovery of function compared with oral NSAIDs in patients with adhesive capsulitis: a randomized controlled trial. Am J Sports Med 44:474–481. doi:10.​1177/​0363546515616238​ CrossRefPubMed
10.
go back to reference Kibar S, Dalyan Aras M, Unsal Delialioglu S (2016) The risk factors and prevalence of upper extremity impairments and an analysis of effects of lymphoedema and other impairments on the quality of life of breast cancer patients. Eur J Cancer Care (Engl). doi:10.1111/ecc.12433 CrossRef Kibar S, Dalyan Aras M, Unsal Delialioglu S (2016) The risk factors and prevalence of upper extremity impairments and an analysis of effects of lymphoedema and other impairments on the quality of life of breast cancer patients. Eur J Cancer Care (Engl). doi:10.​1111/​ecc.​12433 CrossRef
14.
go back to reference Yang EJ, Park WB, Seo KS, Kim SW, Heo CY, Lim JY (2010) Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol 101:84–91. doi:10.1002/jso.21435 CrossRefPubMed Yang EJ, Park WB, Seo KS, Kim SW, Heo CY, Lim JY (2010) Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol 101:84–91. doi:10.​1002/​jso.​21435 CrossRefPubMed
16.
19.
go back to reference Dorr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61:223–231CrossRef Dorr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61:223–231CrossRef
20.
go back to reference Senkus-Konefka E, Jassem J (2006) Complications of breast-cancer radiotherapy. Clin Oncol (R Coll Radiol) 18:229–235CrossRef Senkus-Konefka E, Jassem J (2006) Complications of breast-cancer radiotherapy. Clin Oncol (R Coll Radiol) 18:229–235CrossRef
24.
go back to reference Kootstra JJ, Dijkstra PU, Rietman H et al (2013) A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection. Breast Cancer Res Treat 139:125–134. doi:10.1007/s10549-013-2509-y CrossRefPubMed Kootstra JJ, Dijkstra PU, Rietman H et al (2013) A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection. Breast Cancer Res Treat 139:125–134. doi:10.​1007/​s10549-013-2509-y CrossRefPubMed
25.
go back to reference Grey RG (1978) The natural history of "idiopathic" frozen shoulder. J Bone Joint Surg Am 60:564PubMed Grey RG (1978) The natural history of "idiopathic" frozen shoulder. J Bone Joint Surg Am 60:564PubMed
26.
go back to reference Griggs SM, Ahn A, Green A (2000) Idiopathic adhesive capsulitis. A prospective functional outcome study of nonoperative treatment. J Bone Joint Surg Am 82-A:1398–1407CrossRef Griggs SM, Ahn A, Green A (2000) Idiopathic adhesive capsulitis. A prospective functional outcome study of nonoperative treatment. J Bone Joint Surg Am 82-A:1398–1407CrossRef
Metadata
Title
Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment
Authors
Seoyon Yang
Dae Hwan Park
Sei Hyun Ahn
Jisun Kim
Jong Won Lee
Jun Young Han
Dong Kyu Kim
Jae Yong Jeon
Kyoung Hyo Choi
Won Kim
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3532-4

Other articles of this Issue 4/2017

Supportive Care in Cancer 4/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine